Geospatial analysis of individual-based Parkinson's disease data supports a link with air pollution: A case-control study.


Journal

Parkinsonism & related disorders
ISSN: 1873-5126
Titre abrégé: Parkinsonism Relat Disord
Pays: England
ID NLM: 9513583

Informations de publication

Date de publication:
02 2021
Historique:
received: 02 09 2020
revised: 18 12 2020
accepted: 18 12 2020
pubmed: 22 1 2021
medline: 28 12 2021
entrez: 21 1 2021
Statut: ppublish

Résumé

The etiology of Parkinson's disease (PD) remains unknown. To approach the issue of PD's risk factors from a new perspective, we hypothesized that coupling the geographic distribution of PD with spatial statistics may provide new insights into environmental epidemiology research. The aim of this case-control study was to examine the spatial dependence of PD prevalence in the Canton of Geneva, Switzerland (population = 474,211). PD cases were identified through Geneva University Hospitals, private neurologists and nursing homes medical records (n = 1115). Controls derived from a population-based study (n = 12,614) and a comprehensive population census dataset (n = 237,771). All individuals were geographically localized based on their place of residence. Spatial Getis-Ord Gi* statistics were used to identify clusters of high versus low disease prevalence. Confounder-adjustment was performed for age, sex, nationality and income. Tukey's honestly significant difference was used to determine whether nitrogen dioxide and particulate matters PM Confounder-adjustment greatly reduced greatly the spatial association. Characteristics of the geographic space influenced PD prevalence in 6% of patients. PD hotspots were concentrated in the urban centre. There was a significant difference in mean annual nitrogen dioxide and PM PD prevalence exhibited a spatial dependence for a small but significant proportion of patients. A positive association was detected between PD clusters and air pollution. Our data emphasize the multifactorial nature of PD and support a link between PD and air pollution.

Sections du résumé

BACKGROUND
The etiology of Parkinson's disease (PD) remains unknown. To approach the issue of PD's risk factors from a new perspective, we hypothesized that coupling the geographic distribution of PD with spatial statistics may provide new insights into environmental epidemiology research. The aim of this case-control study was to examine the spatial dependence of PD prevalence in the Canton of Geneva, Switzerland (population = 474,211).
METHODS
PD cases were identified through Geneva University Hospitals, private neurologists and nursing homes medical records (n = 1115). Controls derived from a population-based study (n = 12,614) and a comprehensive population census dataset (n = 237,771). All individuals were geographically localized based on their place of residence. Spatial Getis-Ord Gi* statistics were used to identify clusters of high versus low disease prevalence. Confounder-adjustment was performed for age, sex, nationality and income. Tukey's honestly significant difference was used to determine whether nitrogen dioxide and particulate matters PM
RESULTS
Confounder-adjustment greatly reduced greatly the spatial association. Characteristics of the geographic space influenced PD prevalence in 6% of patients. PD hotspots were concentrated in the urban centre. There was a significant difference in mean annual nitrogen dioxide and PM
CONCLUSION
PD prevalence exhibited a spatial dependence for a small but significant proportion of patients. A positive association was detected between PD clusters and air pollution. Our data emphasize the multifactorial nature of PD and support a link between PD and air pollution.

Identifiants

pubmed: 33476876
pii: S1353-8020(21)00002-X
doi: 10.1016/j.parkreldis.2020.12.013
pii:
doi:

Substances chimiques

Particulate Matter 0
Nitrogen Dioxide S7G510RUBH

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

41-48

Informations de copyright

Copyright © 2021 The Authors. Published by Elsevier Ltd.. All rights reserved.

Auteurs

Vanessa Fleury (V)

Division of Neurology, Geneva University Hospitals, 1211, Geneva 14, Switzerland; Faculty of Medicine, University of Geneva, CMU, 1211, Geneva 4, Switzerland. Electronic address: Vanessa.FleuryNissen@hcuge.ch.

Rebecca Himsl (R)

Unit of Population Epidemiology, Division of Primary Care Medicine, Department of Primary Care Medicine, Geneva University Hospitals, 1211, Geneva 14, Switzerland; Geographic Information Research and Analysis in Population Health (GIRAPH) Group, Geneva University Hospitals, Geneva and Ecole Polytechnique Fédérale de Lausanne (EPFL), 1015, Lausanne, Switzerland; Laboratory of Geographical Information Systems (LASIG), School of Architecture, Civil and Environmental Engineering (ENAC), Ecole Polytechnique Fédérale de Lausanne (EPFL), 1015, Lausanne, Switzerland.

Stéphane Joost (S)

Geographic Information Research and Analysis in Population Health (GIRAPH) Group, Geneva University Hospitals, Geneva and Ecole Polytechnique Fédérale de Lausanne (EPFL), 1015, Lausanne, Switzerland; Laboratory of Geographical Information Systems (LASIG), School of Architecture, Civil and Environmental Engineering (ENAC), Ecole Polytechnique Fédérale de Lausanne (EPFL), 1015, Lausanne, Switzerland; La Source, School of Nursing, University of Applied Sciences and Arts Western Switzerland (HES-SO), Lausanne, Switzerland.

Nicolas Nicastro (N)

Division of Neurology, Geneva University Hospitals, 1211, Geneva 14, Switzerland; Department of Psychiatry, University of Cambridge, UK.

Matthieu Bereau (M)

Division of Neurology, Geneva University Hospitals, 1211, Geneva 14, Switzerland.

Idris Guessous (I)

Faculty of Medicine, University of Geneva, CMU, 1211, Geneva 4, Switzerland; Unit of Population Epidemiology, Division of Primary Care Medicine, Department of Primary Care Medicine, Geneva University Hospitals, 1211, Geneva 14, Switzerland; Geographic Information Research and Analysis in Population Health (GIRAPH) Group, Geneva University Hospitals, Geneva and Ecole Polytechnique Fédérale de Lausanne (EPFL), 1015, Lausanne, Switzerland.

Pierre R Burkhard (PR)

Division of Neurology, Geneva University Hospitals, 1211, Geneva 14, Switzerland; Faculty of Medicine, University of Geneva, CMU, 1211, Geneva 4, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH